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The chemistry of scrapie infection: implications 
of the ‘ice 9’ metaphor 
The transmissible spongiform encephalopathies pose an increasing problem for 
animal, and perhaps human, health. The infectious agent seems to lack a 
nucleic acid component, posing the question of how it can reproduce. 
A model of reproduction by nucleated polymerization suggests 
a number of novel approaches to the problem. 
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The transmissible neurodegenerative disease scrapie has 
fascinated neurobiologists and virologists alike since the 
discovery, over thirty years ago, that the infectious agent 
is much more resistant: to inactivation than a typical 
virus. Subsequent work suggested that the agent consists 
of a single, host-encoded protein, designated the prion 
protein. The proposal that the scrapie infectious agent 
is an ordered aggregate of a normal cellular protein has 
broad implications for experimental approaches to the 
mechanism of infection and pathogenesis. Here we 
briefly review the aggregate hypothesis and its 
implications for research into scrapie and related diseases 
such as Creutzfeldt-Jacob disease (CJD), Kuru, bovine 
spongiform encephalopathy (BSE), and perhaps also 
Alzheimer’s disease. 
Ice nine revisited? 
In Kurt Vonnegut’s novel C& Cradle [l], the physicist 
Felix Hoenikker creates ice 9, the most terrible weapon 
the world has ever seen. Hoenikker’s ice 9 is more 
stable than normal ice (it melts at 114.4” Fahrenheit!), 
but is kinetically inaccessible under standard conditions, 
presumably because nucleation is extremely slow. Felix’s 
son Newt demonstrates that ice 9 crystals seed their 
own replication, and, in the process, wipes out the 
world’s water supply. This concept was revived by the 
popular press in the mid 19605, in the wake of Russian 
reports of a new form of water, ‘polywater’ [2]. Polywater 
later proved to be an experimental artifact [2]. But the 
notion that a kinetically inaccessible, but thermodynami- 
cally stable, form of a natural material could be very 
dangerous may be relevant to a fascinating class of 
neurodegenerative diseases, the transmissible spongiform 
encephalopathies (TSEs). 
The TSEs, like Alzheimer’s disease, are characterized by 
the deposition of insoluble protein in the brain [3-51. 
Despite their rare occurrence in man, these diseases have 
received a huge amount of attention due to their 
prevalence in the livestock population (scrapie in sheep 
and BSE in cattle) and the discovery that they can be 
transmitted by a virus-like agent [3,4]. Recent cases of 
TSE among other mammalian species in Great Britain, 
apparently due to BSE,-infected feed [6], have caused 
concern that this disease could cross species barriers and 
spread to the human population [7,8]. There is some 
precedent for oral transmission of this disease in humans: 
kuru, a prevalent TSE among the primitive tribes of 
New Guinea, was spread by the traditional funeral ritual, 
which included consumption of the brains of ones 
ancestors [3].The agent which causes all of the TSEs has 
been called a slow virus [3], a prion [4], and, aptly, an 
unconventional virus. Like a computer virus, it may bear 
little physical resemblance to a typical virus. 
The infectious agent is virus-like, but no agent-specific 
nucleic acid has been detected 
In the early 1960’s, scrapie was transmitted to rodents 
and the study of the infective agent began. The agent 
proved to be resistant to harsh chemical and enzymatic 
treatments which inactivate typical viruses [9,10]. 
Analysis of the infective agent suggested that it comprises 
primarily one protein [11,12], with no specific nucleic 
acid component, despite the fact that it exhibits three 
biological characteristics that are traditionally associated 
with viruses. First, the agent replicates in viva. Second, 
infectivity is subject to species barriers. Last, strains of the 
scrapie agent have been isolated. Despite being derived 
from the same host, these infective isolates produce dis- 
tinct symptoms and pathologies, showing differences 
both in the time course of pathogenesis and onset of 
symptoms and in the location of the abnormal pathology 
in the brain [13]. The strains have been propagated 
by serial passage in experimental animals. In 1993, one 
of us presented a testable mechanistic explanation of 
scrapie infection [14,15], based on experimental models 
[14,16] and existing general proposals [3,17,18], which 
reconciles the apparently contradictory biological and 
chemical properties of the infectious agent [ 14-161. That 
mechanism is elaborated below. 
How could a protein self-replicate? 
The insoluble proteinaceous deposits that characterize 
scrapie pathology are infectious [3,4,12].These deposits 
appear to consist predominantly of a single protein 
[11,12], designated the prion protein (PrP) [4]. The 
form of the prion protein associated with infection 
(PrP-scrapie, PrPsc) is extremely insoluble and protease- 
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resistant, in contrast to the normal, cellular form of the 
protein (PrP-cellular, PrPC). No covalent chemical dif- 
ference between PrPC and PrPSC has been demon- 
strated, however. Host PrPC is the precursor of PrPSC 
[ 191 and is required for scrapie infection [20]. 
In 1967, J. S. Griffith [17] suggested that the infectious 
scrapie protein is a conformational isomer of a normal 
host protein. Subsequent isolation of the prion protein 
allowed Fourier-transform infrared spectroscopy studies 
of PrPC and PrPSC, which suggested a structural differ- 
ence, supporting this notion [21,22].The in vivo conver- 
sion of PrPC into PrPSC must be very slow, since 
endogenous levels of PrP c do not normally result in 
disease (sporadic CJD is extremely rare). Scrapie 
infection may result from acceleration of this conversion 
by exogenous PrPsc. 
Griffith [17] suggested several possible ways in which a 
‘protein-only’ infectious agent could self-replicate in 
vivo. One suggested mechanism, which has been mod- 
ified and elaborated [4,22-241, holds that PrPSC and 
PrPc are stable, noninterconverting, monomeric confor- 
mational isomers of PrP and that the barrier to sporadic 
disease is the slow conformational change from PrPc to 
PrPsc. No protein is known to exist in several noninter- 
converting monomeric conformations [25], however, let 
alone the fifteen to twenty required to explain the iso- 
lated strains of PrPSC [26]. Furthermore, the mechanism 
proposed to explain infection, catalysis of the slow 
PrPc-to-PrPsc conformational change via PrPc-PrPsc 
heterodimer formation, is unprecedented [14,15]. 
An ordered aggregate can self-replicate by nucleated 
polymerization 
We believe that the difference between the cellular and 
infectious forms of the prion protein is primarily one of 
quaternary structure, and that the differences in protein 
conformation seen are a consequence of this. This type 
of phenomenon has been observed in other systems. 
The components of many insoluble ordered protein 
aggregates (for example, bacterial flagella) are conforma- 
tionally distinct from their soluble, monomeric protein 
subunit [27]. The aggregating species is often not the 
most stable monomeric conformer, but an easily accessi- 
ble minor conformer which is trapped and stabilized by 
intermolecular interactions. Indeed, the allosteric transi- 
tion model of Monod and Changeux [28] is based on 
the stabilization, by intermolecular interactions, of an 
accessible, albeit rare, soluble conformer. One striking 
example of the stabilizing effect of intermolecular inter- 
actions is a lysozyme mutant that crystallizes in two 
forms containing five distinct conformers [29]. By 
analogy, the conformation of PrP monomer found in 
PrPSC may be sparsely populated at equilibrium but easily 
accessible under physiological conditions. Exchange 
between the two PrP forms would pose no problems 
unless the PrP concentration exceeded the critical con- 
centration, at which point nucleation could occur, 
leading to formation of PrPsc. Nucleus formation is slow 
relative to subsequent rapid growth (Fig. 1) and can be 
extremely sensitive to protein concentration [ 151. 
Nucleation could be the slow step in spontaneous disease 
We believe that nucleation of polymerization, rather 
than a unimolecular conformational change, is the rate- 
determining step in PrPSC formation [14,15]. At a phys- 
iologically realistic PrP concentration, slightly in excess 
of its thermodynamic solubility, nucleation would be 
extremely slow, explaining the rarity of sporadic disease. 
Slight increases in the concentration of PrP in vivo 
would have dramatic effects on the rate of nucleation, 
however. Mutations in the PrP gene that either increase 
the concentration of PrP or favor the protein-protein 
associations which precede nucleation even by a small 
amount would have a large overall effect on the rate of 
nucleus formation, explaining the ‘all or none’ genetics 
of CJD [14-161. This would also explain the observed 
correlation between PrP genotype and the occurrence 
of sporadic CJD [16], and the variation in the severity 
of different PrP point mutations. Similarly, a point 
mutation on the hemoglobin surface facilitates the 
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Fig. 1. Nucleus formation is the kinetic 
barrier to sporadic TSE, but is bypassed 
by infection. Nucleus formation is very 
slow at concentrations slightly exceed- 
ing the critical concentration. Small 
increases in PrP concentration would 
greatly increase the rate of nucleation 
[15]. Mutations in PrP that cause CJD 
may affect the unfolding equilibrium 
(PrPU is an unfolded form of PrP) or 
may affect the association equilibria 
1141. Infection results from seeding of 
PrP polymerization, by preformed 
PrPSC nuclei. All of the oligomers 
shown would be effective seeds, 
however, only the high molecular 
weight oligomers would be easily 
observable by electron microscopy. 
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Fig. 2. Barriers to interspecies infection 
result from packing defects. Slight struc- 
tural differences between the species 
PrPs may affect the efficiency of seeding 
or may prevent seeding altogether. In 
the figure, three species variants of PrP 
are represented by three shapes. The 
intraspecies seeding is clearly most effi- 
cient. lnterspecies heterologous seeding 
can occur if the structural differences 
are small (for example, the species 
barrier between mouse and hamster is 
permeable). However, if the structural 
differences are large, interspecies 
seeding may not be effective at all (we 
hope, for example, that the barrier 
between sheep or cow and human is 
impermeable). The best known example 
of heterologous nucleation is cloud 
seeding, which was the field of Kurt 
Vonnegut’s brother. 
Hamster PrP Mouse PrP 
iamster seed (PrPSC) Mouse seed (PrPSC 
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nucleation-dependent formation of the ordered sickle- 
cell hemoglobin fibril [ 151. 
Infection may involve transfer of a preformed seed 
We have proposed that the scrapie infectious agent con- 
tains an oligomeric form of PrP (PrPsc), which acts as a 
nucleus, or seed, for the polymerization of the cellular 
protein (PrPc) [14,15]. The nucleus, shown in Fig. 1 as a 
six-mer, is defined as the smallest oligomer which can act 
as a seed. At a PrP concentration slightly exceeding its 
thermodynamic solubility, nucleation would be very 
slow (sporadic disease, Fig. l), but seeded growth (infec- 
tion, Fig. 1) would readily occur [15]. Achieving such 
PrP concentrations in ttivo may require sequestration of 
the protein in a cellular compartment such as an endo- 
some or a lysosome. In fact, there is evidence that PrPSC 
is formed along the endocytic pathway from the plasma 
membrane. [19,30,31]. 
Replication 
The infective scrapie agent replicates in the host animal, 
making it possible, by serial passage of the agent, to infect 
large numbers of animals starting with a small amount of 
PrPsc. In our model, this could be explained by the idea 
that the PrPSC aggregate can be fragmented to produce 
multiple seeds, each of which can be a template for 
further polymerization of host PrP. Fragmentation of 
amyloid fibrils by sonication increases seeding eficiency 
[ 14,151. Similarly, dispersion of prion fibrils increases 
infectivity, presumably by producing many oligomeric 
seeds; these may be too small to be easily observable by 
electron microscopy, however [4]. 
Species barriers 
The induction period for interspecies infection is much 
longer than for intraspecies infection.The species barrier 
is presumably due to PrP sequence differences among 
the species (Fig. 2). If the interaction between seed PrPSC 
of one species and the host PrP of another species is not 
optimal, the growth of PrPSC may be slower, or entirely 
prevented [32]. Once the initial barrier is overcome, 
however, the resulting PrPSC would be essentially indis- 
tinguishable from host agent in subsequent passages [4], 
since the seed PrPsc was present only in trace amounts. 
This is in fact what is observed in interspecies infection; 
the incubation time for transfer of infection from mouse 
to hamster is long, but shortens in subsequent hamster to 
hamster transfers. 
Strains 
Perhaps the most puzzling phenomenon in scrapie is the 
existence of scrapie strains which, despite the fact that 
the PrPSC isolates are identical with respect to sequence, 
behave differently with respect to the induction period 
and the resultant disease pathology [13]. The nucleation- 
dependent mechanism of PrPSC formation provides a 
simple explanation; strains of PrPSC may represent alter- 
nately packed ordered PrP aggregates (Fig. 3), analogous 
to the various forms of ice that inspiredVonnegut’s ice 9 
[l]. Alternative PrP packing modes (PrPsc‘ strains) may 
arise from nuclei of different sizes (for example, 5,6, or 7 
monomers per nucleus, Fig. 3) and/or configurations. 
(for example, rectangles can pack along the long or the 
short side, Fig. 3). The PrP monomer conformation in 
each strain may be identical (as is the case for ices l-9) 
or slightly different. Examples of alternately packed 
protein crystals include aldolase [33] and a lysozyme 
mutant [29] which have been shown to produce different 
crystal forms, depending on the crystallization condi- 
tions. Identical flagellin monomers can form straight or 
curly flagella [27]. The preferred PrP aggregation 
pathway would be very sensitive to PrP concentration 
(for example, lower PrP concentration would favor 
smaller nuclei) and various endogenous factors (for 
example, pH and/or salt concentration may affect inter- 
molecular interactions). If the energetic difference 
between the nucleation pathways is small, our model 
would predict that several strains could arise in one 
animal. The strains could be isolated during the 
isolation/dilution/injection protocol of experimental 
serial passage. Propagation of the scrapie agent strains 
resembles the seeding of a crystallization. In the presence 
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Fig. 3. Strains might originate from alter- 
nately packed nuclei and be propagated 
by seeding. The various scrapie strains 
may simply be alternately packed PrP 
polymers, for example having different 
sizes of nucleus or different configura- 
tions of the monomer within the 
nucleus. Nuclei of five, six and seven 
monomers, with two different monomer 
configurations, are shown. Several 
strains could arise in a single animal if 
the differences between activation ener- 
gies for formation of the various nuclei 
were small. It would then be possible to 
propagate the strains by seeding. 
of seed PrPSC, the PrP of the host will take on the strain 
properties of the infecting PrPSC because the nucleus 
imposes its own periodicity on the polymer whose 
formation it seeds. 
Implications of the nucleated polymerization hypothesis 
Driven by the hypothesis that nucleation of PrP 
polymerization is the rate-determining step of PrPSC 
formation, we set out to develop a cell-free system to 
study the mechanism of the PrPC to PrPsc conversion 
[34]. Previous attempts to develop cell-free conversion 
systems were based on the premise that monomeric 
PrPSC directly catalyzes the conversion of a monomer of 
PrPC to the PrPSC conformation, and were unsuccessful. 
This prompted speculation that a cofactor, possibly ATP 
or a chaperonin, is required for the PrP conformational 
change [22,35,36]. W e were able to show, however, that 
by unfolding PrPC and increasing the concentration of 
PrPSC relative to PrPC it is possible to catalyze the 
conversion of PrPC to the PrPSC form. Presumably this is 
because our system provides a sufficient number of 
template nuclei to capture and stabilize the PrP 
monomers that adopt the PrPSC conformation. 
The success of our system suggests that a separate 
cofactor is not essential in vitro.We cannot rule out the 
possibility that a cofactor that copurifies with PrPSC is 
required, however. The ultimate proof of the ‘protein- 
only’ hypothesis will be the in vitro creation of PrPSC 
from purified PrPC and the proof that this material is 
infectious. This would not preclude, of course, the pos- 
sibility that other proteins might be involved in infec- 
tion or in the generation of spontaneous disease in vivo. 
The recent report that apoE genotype is a major sus- 
ceptibility factor for CJD [37] suggests that the apoE 
protein may be involved in the process of spontaneous 
PrPSC ‘seed’ formation, either as an inhibitor or as a pro- 
moter. The apoE proteins have been reported, by differ- 
ent research groups, to exert both of these effects on in 
vitro amyloid formation by the p amyloid protein of 
Alzheimer’s disease [38,39]. 
Consequences for experimental design 
Using the cell-free system mentioned above, it should be 
possible to use existing methods to detect interactions 
between the PrP protein and apoE or other auxiliary 
proteins. In designing these experiments, it is crucial to 
recognize the possibility that the auxiliary protein may 
interact not with the PrP monomer, but with a PrP 
oligomer or seed [38]. In addition, the binding of PrPSC 
and PrPc to sulfated glycosaminoglycans [40,41] and the 
potent inhibition of PrP sc formation and scrapie agent 
replication by sulfated glycosaminoglycan analogs and 
Congo red [42-441 suggest that sulfated proteoglycans 
may have a critical role in in vivo PrPSC. formation. 
Several aspects of the proposal outlined above now call 
for detailed testing using cell-free systems. For example, 
the notion that different strains of PrPSC represent 
alternatively packed forms of monomers is now testable. 
If this hypothesis turns out to be correct, other questions 
arise. What are the features of the protein structure that 
make the different forms of aggregate possible? How 
does a PrP aggregate interact with the PrP monomer of 
another species? And what bearing, if any, does this have 
on the function of PrPC in the normal brain? 
Finally there is the critical question of how PrPSC kills 
neurons. It is possible that the damage simply results from 
the abnormal protein precipitation caused by aggregation 
of PrI? Alternatively, PrPsc may interact with a specific 
cellular protein. Again, the search for a cellular target of 
PrPSC may require methodology specifically designed to 
discover monomer-aggregate interactions. We look 
forward to experimental tests of the idea that aggregation 
is important in the formation of PrPSC, and, should it be 
proved correct, to exploring the further implications of 
the notion as outlined above. 
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